NO129481B - - Google Patents
Download PDFInfo
- Publication number
- NO129481B NO129481B NO01954/70A NO195470A NO129481B NO 129481 B NO129481 B NO 129481B NO 01954/70 A NO01954/70 A NO 01954/70A NO 195470 A NO195470 A NO 195470A NO 129481 B NO129481 B NO 129481B
- Authority
- NO
- Norway
- Prior art keywords
- antigen
- film
- test
- synthetic
- serological
- Prior art date
Links
- 238000000034 method Methods 0.000 claims description 19
- 239000000427 antigen Substances 0.000 claims description 17
- 102000036639 antigens Human genes 0.000 claims description 16
- 108091007433 antigens Proteins 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 16
- 239000000725 suspension Substances 0.000 claims description 16
- 229910052751 metal Inorganic materials 0.000 claims description 13
- 239000002184 metal Substances 0.000 claims description 13
- 230000000405 serological effect Effects 0.000 claims description 13
- 239000000243 solution Substances 0.000 claims description 13
- 239000004816 latex Substances 0.000 claims description 7
- 229920000126 latex Polymers 0.000 claims description 7
- 239000002966 varnish Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000003899 bactericide agent Substances 0.000 claims description 6
- 210000003743 erythrocyte Anatomy 0.000 claims description 5
- 241001494479 Pecora Species 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229920003002 synthetic resin Polymers 0.000 claims description 4
- 239000000057 synthetic resin Substances 0.000 claims description 4
- 239000011521 glass Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- -1 sodium thiazide Chemical class 0.000 claims description 3
- 239000003451 thiazide diuretic agent Substances 0.000 claims description 3
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 3
- 239000012620 biological material Substances 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 229920001059 synthetic polymer Polymers 0.000 claims description 2
- 229940068492 thiosalicylate Drugs 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 description 12
- 229920002451 polyvinyl alcohol Polymers 0.000 description 12
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 12
- 239000004372 Polyvinyl alcohol Substances 0.000 description 11
- 210000002966 serum Anatomy 0.000 description 9
- 239000000463 material Substances 0.000 description 6
- 229940015047 chorionic gonadotropin Drugs 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 4
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Substances O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- 108010074605 gamma-Globulins Proteins 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 229920000609 methyl cellulose Polymers 0.000 description 4
- 239000001923 methylcellulose Substances 0.000 description 4
- 235000010981 methylcellulose Nutrition 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000001685 thyroid gland Anatomy 0.000 description 4
- 239000004793 Polystyrene Substances 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 229920000877 Melamine resin Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920001807 Urea-formaldehyde Polymers 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- IVJISJACKSSFGE-UHFFFAOYSA-N formaldehyde;1,3,5-triazine-2,4,6-triamine Chemical compound O=C.NC1=NC(N)=NC(N)=N1 IVJISJACKSSFGE-UHFFFAOYSA-N 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 201000006747 infectious mononucleosis Diseases 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- ODGAOXROABLFNM-UHFFFAOYSA-N polynoxylin Chemical compound O=C.NC(N)=O ODGAOXROABLFNM-UHFFFAOYSA-N 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 238000009597 pregnancy test Methods 0.000 description 2
- 239000011253 protective coating Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- RTVRBWMZXZDOAZ-UHFFFAOYSA-M (2-carboxyphenyl)sulfanyl-ethylmercury;sodium Chemical compound [Na].CC[Hg+].[O-]C(=O)C1=CC=CC=C1S RTVRBWMZXZDOAZ-UHFFFAOYSA-M 0.000 description 1
- IWYGVDBZCSCJGT-UHFFFAOYSA-N 1-(2,5-dimethoxy-4-methylphenyl)-n-methylpropan-2-amine Chemical compound CNC(C)CC1=CC(OC)=C(C)C=C1OC IWYGVDBZCSCJGT-UHFFFAOYSA-N 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 208000024799 Thyroid disease Diseases 0.000 description 1
- 229920000180 alkyd Polymers 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 238000007666 vacuum forming Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUVA1309A HU162690B (fr) | 1969-05-24 | 1969-05-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO129481B true NO129481B (fr) | 1974-04-16 |
Family
ID=11002274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO01954/70A NO129481B (fr) | 1969-05-24 | 1970-05-22 |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS4948732B1 (fr) |
| AT (1) | AT306921B (fr) |
| AU (1) | AU1543770A (fr) |
| BE (1) | BE750849A (fr) |
| BG (1) | BG20078A3 (fr) |
| BR (1) | BR7019244D0 (fr) |
| CH (1) | CH536627A (fr) |
| DE (1) | DE2023989C3 (fr) |
| DK (1) | DK124988B (fr) |
| FR (1) | FR2053902A5 (fr) |
| GB (1) | GB1316876A (fr) |
| HU (1) | HU162690B (fr) |
| IE (1) | IE34175B1 (fr) |
| IL (1) | IL34544A (fr) |
| LU (1) | LU60961A1 (fr) |
| NL (1) | NL7007469A (fr) |
| NO (1) | NO129481B (fr) |
| PL (1) | PL72768B1 (fr) |
| RO (1) | RO62161A (fr) |
| SE (1) | SE376090B (fr) |
| ZA (1) | ZA703369B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA702304B (en) * | 1969-04-22 | 1971-01-27 | Org Nv | Diagnostic test slide |
| US4136162A (en) | 1974-07-05 | 1979-01-23 | Schering Aktiengesellschaft | Medicament carriers in the form of film having active substance incorporated therein |
| JPS5338235U (fr) * | 1976-09-08 | 1978-04-04 | ||
| JPS5340649U (fr) * | 1976-09-13 | 1978-04-08 | ||
| DE2709625C3 (de) * | 1977-03-05 | 1982-03-04 | Battelle-Institut E.V., 6000 Frankfurt | Verfahren zur wissenschaftlichen, analytischen oder diagnostischen Untersuchung |
| IT1114861B (it) * | 1977-05-12 | 1986-01-27 | Sclavo Inst Sieroterapeut | Metodo per la determinazione del contenuto di costituenti di fluidi biologici e mezzi adatti allo scopo |
| US4234316A (en) | 1979-04-02 | 1980-11-18 | Fmc Corporation | Device for delivering measured quantities of reagents into assay medium |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU767266A (en) * | 1966-06-29 | 1968-01-04 | Beecham Group Limited | Means for testing the supersensitivity ofthe skin |
| ZA702304B (en) * | 1969-04-22 | 1971-01-27 | Org Nv | Diagnostic test slide |
-
1969
- 1969-05-24 HU HUVA1309A patent/HU162690B/hu unknown
-
1970
- 1970-05-15 DE DE2023989A patent/DE2023989C3/de not_active Expired
- 1970-05-18 ZA ZA703369A patent/ZA703369B/xx unknown
- 1970-05-18 IL IL34544A patent/IL34544A/en unknown
- 1970-05-19 GB GB2409870A patent/GB1316876A/en not_active Expired
- 1970-05-20 IE IE661/70A patent/IE34175B1/xx unknown
- 1970-05-20 CH CH746670A patent/CH536627A/de not_active IP Right Cessation
- 1970-05-20 AT AT450170A patent/AT306921B/de not_active IP Right Cessation
- 1970-05-21 FR FR7018599A patent/FR2053902A5/fr not_active Expired
- 1970-05-22 DK DK264670AA patent/DK124988B/da unknown
- 1970-05-22 NO NO01954/70A patent/NO129481B/no unknown
- 1970-05-22 NL NL7007469A patent/NL7007469A/xx unknown
- 1970-05-22 BR BR219244/70A patent/BR7019244D0/pt unknown
- 1970-05-22 SE SE7007090A patent/SE376090B/xx unknown
- 1970-05-22 LU LU60961D patent/LU60961A1/xx unknown
- 1970-05-22 BE BE750849D patent/BE750849A/xx unknown
- 1970-05-22 AU AU15437/70A patent/AU1543770A/en not_active Expired
- 1970-05-23 BG BG014769A patent/BG20078A3/xx unknown
- 1970-05-23 PL PL1970140830A patent/PL72768B1/pl unknown
- 1970-05-25 RO RO63441A patent/RO62161A/ro unknown
- 1970-05-25 JP JP45044104A patent/JPS4948732B1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU1543770A (en) | 1971-11-25 |
| IL34544A (en) | 1973-05-31 |
| HU162690B (fr) | 1973-03-28 |
| SE376090B (fr) | 1975-05-05 |
| IE34175B1 (en) | 1975-02-19 |
| CH536627A (de) | 1973-05-15 |
| PL72768B1 (fr) | 1974-08-30 |
| DE2023989B2 (de) | 1973-09-20 |
| RO62161A (fr) | 1977-05-15 |
| GB1316876A (en) | 1973-05-16 |
| IL34544A0 (en) | 1970-07-19 |
| ZA703369B (en) | 1971-01-27 |
| IE34175L (en) | 1970-11-24 |
| AT306921B (de) | 1973-04-25 |
| NL7007469A (fr) | 1970-11-26 |
| BE750849A (fr) | 1970-11-03 |
| DK124988B (da) | 1972-12-18 |
| BR7019244D0 (pt) | 1973-02-08 |
| LU60961A1 (fr) | 1970-07-23 |
| JPS4948732B1 (fr) | 1974-12-23 |
| DE2023989C3 (de) | 1974-04-18 |
| FR2053902A5 (fr) | 1971-04-16 |
| BG20078A3 (bg) | 1975-10-30 |
| DE2023989A1 (de) | 1970-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3088875A (en) | Immunological diagnostics utilizing polystyrene latex particles of 0.15 to 0.25 micron | |
| CN103901208B (zh) | 能够更好地在医疗制品中检测非内毒素致热污染物的改进的单核细胞活化测试 | |
| CN106370861B (zh) | 一种c反应蛋白唾液检测试纸条及其制备方法 | |
| Badin et al. | Plasma polysaccharide fraction containing uronic acid, in normal subjects and in patients with rheumatoid arthritis | |
| Heidelberger et al. | Chemical Studies on Bacterial Agglutination: Ii. the Identity of Precipitin and Agglutinin | |
| KR0126236B1 (ko) | 완전 세포에 적용할 수 있는 면역측정분석 키트 및 방법 | |
| NO129481B (fr) | ||
| US3914400A (en) | Stable antigen-erythrocytes for measuring antibodies against toxoplasma organism | |
| US3562384A (en) | Immunological indicator and test system | |
| Hakala et al. | Cell mediated cytotoxicity against human transitional cell carcinomas of the genitourinary tract | |
| Fritz et al. | Hepatitis-associated antigen: detection by antibody-sensitized latex particles | |
| Cox | Preservation of sheep erythrocytes and their use in a rapid plate titration of heterophilic antibodies in infectious mononucleosis | |
| CN116430036B (zh) | 一种滤血膜检测装置及制备方法和应用 | |
| Koller et al. | Lupus erythematosus cell preparation-antinuclear factor incongruity: a review of diagnostic tests for systemic lupus erythematosus | |
| US6461825B1 (en) | Immunometric assay kit and method applicable to whole cells | |
| JP2018173334A (ja) | 免疫学的測定方法及びそれに用いる試薬キット | |
| CN217846340U (zh) | 一种非自体抗原特异性抗体的快速检测卡及试剂盒 | |
| US3426123A (en) | Diagnostic test for infectious mononucleosis with aldehyde treated equine erythrocytes | |
| Eaton et al. | Maternal to fetal movement of creatinine as a measure of perfusion efficiency and diffusional transfer in the isolated human placental lobule | |
| US2111976A (en) | Test for syphilis and the process of preparing the reagent used in performing the test | |
| Gordon et al. | Charcoal particle agglutination test for detection of antibody to Cryptococcus neoformans: a preliminary report | |
| Fife Jr et al. | Isolation and characterization of a serologically active exoantigen of Schistosoma mansoni cercariae | |
| CN108872605A (zh) | 一种美洲锥虫病的检测试剂盒及其检测方法 | |
| Del Prete et al. | Epidemic Hepatitis-Associated Antigen (Milan Antigen): Study on Normal Population and Sporadic Acute Viral Hepatitis | |
| US4282002A (en) | Sensitized sheep stroma immunoassay for rheumatoid factor |